Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome
Wesley J. Woollard(King's College London), Sean Whittaker(Guy's Hospital), Varsha Patel, Charlotte E. Flanagan(King's College London), Carl Beyers(King's College London), Tracey J. Mitchell(Guy's Hospital), Anthony Bayega(University of Thessaly), Antoinette Yoxall(King's College London), Elisabeth Nuttall(King's College London), Michael A. Simpson(King's College London), Venu Pullabhatla(National Health Service), Ceri A. Roberts(NHS Blood and Transplant), Nubia Castillo-Mosquera(King's College London), Rebecca L. Tarrant(King's College London), Ricarda M. Hoffmann(Guy's Hospital), Anna Lorenc(Guy's and St Thomas' NHS Foundation Trust), Farrah Bakr(Guy's Hospital), Joshua N. B. Fisher(King's College London), Emanuele de Rinaldis(Target (United States)), Nelema Begum(King's College London), Kiran Dedhia(King's College London), Silvia Aguilar-Durán(King's College London), Isabella Tosi(King's College London), Arisa Paul(King's College London), Rosie M. Butler(Guy's Hospital), Emmanouil G Solomonidis(King's College London), Silvia Ferreira(King's College London), Aria A. Ghasemi(King's College London)
Cited by 109
Related Papers
Interplay between the human gut microbiome and host metabolism
|Nature Communications|2019|784
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543